[1] Okabe-Kado J, Kasukabe T, Baba H, et al. Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells[J]. Biochim Biophys Acta, 1995, 1267(2-3): 101-106.
[2] Fujita Y, Fujiwara K, Zenitani S, et al. Acetylation of NDPK-D re-gulates its subcellular localization and cell survival[J]. PLoS One, 2015, 10(10): e0139616. DOI: 10.1371/journal.pone.0139616.
[3] Lacombe ML, Milon L, Munier A, et al. The human Nm23/nucleoside diphosphate kinases[J]. J Bioenerg Biomembr, 2000, 32(3): 247-258.
[4] Fa KN, Yang CM, Chen PC, et al. Anti-metastatic effects of antrodan, the Antrodia cinnamomea mycelia glycoprotein, in lung carcinoma cells[J]. Int J Biol Macromol, 2015, 74: 476-482. DOI: 10.1016/j.ijbiomac.2015.01.004.
[5] Huang XI, Zhao W, Li Y, et al. Association between nm23 gene po-lymorphisms and the risk of endometriosis[J]. Biomed Rep, 2015, 3(6): 874-878. DOI: 10.3892/br.2015.511.
[6] Wang Z, Li L, Wang Y. Effects of Per2 overexpression on growth inhibition and metastasis, and on MTA1, nm23-H1 and the auto-phagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer[J]. Mol Med Rep, 2016, 13(6): 4561-4568. DOI: 10.3892/mmr.2016.5116.
[7] Ji Q, Zheng GY, Xia W, et al. Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A[J]. Pharm Biol, 2015, 53(5): 773-780. DOI: 10.3109/13880209.2014.941505.
[8] Horak CE, Lee JH, Elkahloun AG, et al. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2[J]. Cancer Res, 2007, 67(15): 7238-7246. DOI: 10.1158/0008-5472.CAN-07-0962.
[9] Chen S, Su L, Qiu J, et al. Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription[J]. Biochim Biophys Acta, 2013, 1830(10): 4769-4777. DOI: 10.1016/j.bbagen.2013.06.007.
[10] Shan C, Lin J, Hou JQ, et al. Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule[J]. Nucleic Acids Res, 2015, 43(14): 6677-6691. DOI: 10.1093/nar/gkv641.
[11] Mata-Greenwood E, Cuendet M, Sher D, et al. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associa-ted with down-regulation of c-myc[J]. Leukemia, 2002, 16(11): 2275-2284. DOI: 10.1038/sj.leu.2402696.
[12] Godfried MB, Veenstra M, v Sluis P, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2[J]. Oncogene, 2002, 21(13): 2097-2101. DOI: 10.1038/sj.onc.1205259.
[13] Lilly AJ, Khanim FL, Hayden RE, et al. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone[J]. Cancer Res, 2011, 71(3): 1177-1186. DOI: 10.1158/0008-5472.CAN-10-1704.
[14] Niitsu N, Okamoto M, Okabe-Kado J, et al. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin′s lymphoma[J]. Leukemia, 2001, 15(5): 832-839.
[15] Niitsu N, Nakamine H, Okamoto M, et al. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma[J]. Br J Haematol, 2003, 123(4): 621-630.
[16] Niitsu N, Nakamine H, Okamoto M, et al. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lym-phoma[J]. Clin Cancer Res, 2004, 10(7): 2482-2490.
[17] Niitsu N, Nakamine H, Okamoto M, et al. A clinicopathological study of nm23-H1 expression in classical Hodgkin′s lymphoma[J]. Ann Oncol, 2008, 19(11): 1941-1946. DOI: 10.1093/annonc/mdn413.
|